ALNY
Alnylam Pharmaceuticals, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +6.7% ·
flujo de acciones -2.5% ·
nuevas posiciones netas +6.2%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 162 | +3 | 107.61M | $32.37B | +7 | −3 |
| Q1 2026 | 161 | -2 | 108.78M | $35.89B | +4 | −7 |
| Q4 2025 | 162 | -2 | 118.83M | $47.26B | +1 | −2 |
| Q3 2025 | 24 | +1 | 85.59M | $39.02B | +2 | −2 |
| Q2 2025 | 21 | -1 | 76.99M | $25.10B | — | −1 |
| Q1 2025 | 19 | +2 | 40.24M | $10.86B | +3 | −1 |
| Q4 2024 | 17 | 0 | 41.95M | $9.87B | — | — |
| Q3 2024 | 16 | +1 | 39.28M | $10.80B | +2 | −1 |
| Q2 2024 | 15 | — | 40.30M | $9.79B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 16.51M | +10.3% | $4.54B | 0.7% | ▲ Add | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 4.95M | -20.2% | $1.36B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.95M | -20.2% | $1.36B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.95M | -20.2% | $1.36B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.95M | -20.2% | $1.36B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.95M | -20.2% | $1.36B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.95M | -20.2% | $1.36B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.95M | -20.2% | $1.36B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 4.95M | -20.2% | $1.36B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 10 | Baillie Gifford ✦ | 4.89M | -19.0% | $1.34B | 1.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Baillie Gifford ✦ | 4.89M | -19.0% | $1.34B | 1.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Baillie Gifford ✦ | 4.89M | -19.0% | $1.34B | 1.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Baillie Gifford ✦ | 4.89M | -19.0% | $1.34B | 1.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Dodge & Cox ✦ | 3.62M | -4.2% | $996.31M | 0.6% | ▼ Trim | 2 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 3.45M | -1.0% | $949.36M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 3.45M | -1.0% | $949.36M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 17 | Norges Bank ✦ (pasivo) | 2.38M | +3.4% | $653.34M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 18 | Geode Capital Management ✦ (pasivo) | 2.15M | +3.2% | $589.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Geode Capital Management ✦ (pasivo) | 2.15M | +3.2% | $589.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 505.65K | +86.2% | $138.95M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 505.65K | +86.2% | $138.95M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 505.65K | +86.2% | $138.95M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 505.65K | +86.2% | $138.95M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 505.65K | +86.2% | $138.95M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 332.31K | +18.9% | $91.39M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 332.31K | +18.9% | $91.39M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 27 | Millennium Management ✦ | 250.96K | +81.2% | $69.02M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 28 | Adage Capital Partners ✦ | 116.00K | -54.3% | $31.90M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 29 | Marshall Wace ✦ | 63.47K | Nuevo | $17.46M | 0.0% | New | 1 | SEC ↗ |
| 30 | Citadel Advisors ✦ | 23.93K | -93.5% | $6.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 23.93K | -93.5% | $6.58M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 32 | Two Sigma Investments ✦ | 19.15K | -81.4% | $5.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 33 | Gotham Asset Management ✦ | 17.57K | +32.8% | $4.83M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 34 | Bridgewater Associates ✦ | 2.00K | Nuevo | $550,610 | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Marshall Wace | $17.46M | 0.0% |
| Bridgewater Associates | $550,610 | 0.0% |
Posición cerrada
| Arrowstreet Capital | $3.64M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 4.30K acciones, $1,422 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.